Perjeta (pertuzumab) is considered a targeted cancer therapy, which is different from chemotherapy. Chemotherapy kills cancer cells that grow rapidly, but may also affect normal cells. Targeted drug therapy like Perjeta attacks HER2 proteins on certain cancer cells that cause rapid growth. However, Perjeta may also affect these proteins on healthy cells (which occur in fewer amounts).